Zobrazeno 1 - 10
of 297
pro vyhledávání: '"P Kaloyannidis"'
Autor:
Kaloyannidis P, George B, Alrustamani A, Khalil C, Al-Charfli B, Al-Moghrabi N, Ibrahim D, Alfar M, Daryahya M, Mheidly K, El-Saddik A, Al-Shamsi HO
Publikováno v:
Journal of Blood Medicine, Vol Volume 15, Pp 471-475 (2024)
Panayotis Kaloyannidis,1 Biju George,1 Ahmad Alrustamani,1 Charbel Khalil,1 Basmah Al-Charfli,1 Nour Al-Moghrabi,1 Dima Ibrahim,2 Mohammed Alfar,3 Mohammed Daryahya,1 Kayane Mheidly,4 Amro El-Saddik,1 Humaid O Al-Shamsi5– 11 1Adult Hematology & Cel
Externí odkaz:
https://doaj.org/article/953b2ac953e64c61945c0b09e0128c4a
Autor:
Eleni Gavriilaki, Eleni Papchianou, Giorgos Karavalakis, Ioannis Batsis, Alkistis Panteliadou, Andriana Lazaridou, Despina Mallouri, Varnavas Constantinou, Paraskevi Karvouni, Paschalis Evangelidis, Anna Papakonstantinou, Apostolia Papalexandri, Panayotis Kaloyannidis, Nikolaos Spyridis, Zoi Bousiou, Anna Vardi, Evangelia Yannaki, Damianos Sotiropoulos, Ioanna Sakellari
Publikováno v:
Pharmaceuticals, Vol 17, Iss 10, p 1279 (2024)
Background/Objectives: Despite novel biological agents, steroid-dependent or -refractory graft-versus-host disease (GvHD) remains a severe complication of allogeneic hematopoietic cell transplantation (allo-HCT). Extracorporeal photopheresis (ECP) is
Externí odkaz:
https://doaj.org/article/c6888a305258428a86c96e26fed3e9f2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of Blood Medicine, Vol Volume 13, Pp 619-630 (2022)
Panayotis Kaloyannidis, Fatema Abdulla, Enas Mutahar, Haidar Al Hashim, Salman Al Harbi, Analie Estanislao, Hani Al Hashmi Adult Hematology and Stem Cell Transplantation Department, King Fahad Specialist Hospital, Dammam, Saudi ArabiaCorrespondence:
Externí odkaz:
https://doaj.org/article/c8550d7b70124f7a80e6e420b1a4297c
Autor:
Humaid O. Al-Shamsi, Amin Abyad, Panayotis Kaloyannidis, Amro El-Saddik, Ahmad Alrustamani, Ibrahim Abu Gheida, Azzam Ziade, Norbert W. Dreier, Urfan Ul-Haq, Thanda Lucy Ann Joshua, Abdul Rahman El Kinge, Ritika Coelho, Dima Ibrahim, Mehdi Afrit, Bilal Al-Lababidi, Zainul Aabideen, Mayur Sabhani, Rakeshkumar Shah, Ghaith Makhlouf, Lana Iskandaerani, Faryal Iqbal, Shiny Narayanan, Mohammed Ameen, Theresa Morrison, Charbel Khalil, Kayane Mheidly
Publikováno v:
Clinics and Practice, Vol 12, Iss 1, Pp 84-90 (2022)
Hematopoietic stem cell transplantation (HSCT) is increasingly indicated for various malignant and non-malignant diseases. In the United Arab Emirates (UAE), patients that could benefit from the procedure commonly need to seek medical care abroad in
Externí odkaz:
https://doaj.org/article/e9cd034fb8404d1b84e221307260ba65
Autor:
Panayotis Kaloyannidis, Belal Blowi, Rana Yahya, Hamdah Al Khaldi, Rabab Attas, Afra Dayel, Solaf Kanfar
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 44, Iss , Pp S17-S18 (2022)
Objective: Patients (pts) who have undergone allogeneic stem cell transplantation (alloSCT) are at high-risk for life-threating complications post SARS-CoV-2 infection, and the mortality rates has been reported of approximately 30-35%. The currently
Externí odkaz:
https://doaj.org/article/c5948b0c15fc43da82f8844ec8fbb07e
Autor:
Panayotis Kaloyannidis, Naeema Al Musailemelime, Abdulelah Al Shami, Manal Al Enazi, Norah Al Mulhem, Ahmed Bahrani, Rabab Attas, Solaf Kanfar
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 44, Iss , Pp S17- (2022)
Objective: The effectiveness of vaccinations post hematopoietic stem cell transplantation (HSCT), is a reliable marker for immune system's functionality assessment. In autologous HSCT (AHSCT) setting, the general aspect is that the immune system reco
Externí odkaz:
https://doaj.org/article/6dfb949224fa457da9f780ce94516eef
Autor:
Panayotis Kaloyannidis, Fatema Abdulla, Enas Mutahar, Haidar Hashim, Salman Harbi, Analie Estanislao, Solaf Ka
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 44, Iss , Pp S33- (2022)
Objective: Multiple myeloma (MM) is considered a disease of elderlies however, 35-40% of newly diagnosed MM (NDMM) patients (pts) are ≤60 years (ys) old. Although young NDMM pts succeed better outcomes with the currently used treatment protocols, a
Externí odkaz:
https://doaj.org/article/b3127f242686407a9f4f61e1f65e3724
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Hematology Reports, Vol 13, Iss 1 (2021)
For patients with Hodgkin Lymphoma (HL) who experience relapse post allogeneic stem cell transplantation, limited treatment options exist, and the ultimate outcome is poor. Recently, the programmed cell death protein-1 (PD-1) inhibitors have shown re
Externí odkaz:
https://doaj.org/article/2c55f0ed380e4f6599a61dbcd9afff9a